Cipla Limited and Roche Products (India) Pvt. Ltd. announced that the two companies have entered into an agreement to provide better access to innovative medicines for patients in India. As part of the agreement, Cipla will be responsible for marketing and distribution of Roche Pharma’s key trademark oncology drugs viz.,Trastuzumab (Herclon), Bevacizumab (Avastin) and Rituximab…